Fas deficiency exacerbates cerulein-induced pancreatitis

Journal of Investigative Surgery

Volumn 16, Issue 6, 2003, Pages 325-333

  Jeyarajah, D Rohan ^a   Kielar, M ^a   Gokaslan, S T ^a   Lindberg, G ^a   Lu, C Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; FAS; Pancreatitis

Indexed keywords

AMYLASE; CERULETIDE; FAS LIGAND;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; DISEASE EXACERBATION; EDEMA; HISTOPATHOLOGY; INFLAMMATION; MOUSE; MOUSE STRAIN; NECROSIS; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0346398418     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930390249865     Document Type: Article

References (33)

1. Karne S, Gorelick FS. Etiopathogenesis of acute pancreatitis. Surg Clin North Am. 1999;79:699-710.
2. Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am. 1999;79:767-781.
3. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest. 2000;106:773-781.
4. Kimura K, Shimosegawa T, Sasano H, Abe R, Satoh A, Masamune A, Koizumi M, Nagura H, Toyota T. Endogenous glucocorticoids decrease the acinar cell sensitivity to apoptosis during cerulein pancreatitis in rats. Gastroenterology. 1998;114:372-381.
5. Hartwig W, Jimenez RE, Werner J, Lewandrowski KB, Warshaw AL, Fernandez-del Castillo C. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology. 1999;117:717-725.
6. Lerch MM, Gorelick FS. Early trypsinogen activation in acute pancreatitis. Med Clin North Am. 2000;84:549-563.
7. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 1996;93:2239-2244.
8. Barinaga M. Forging a path to cell death: Researchers are uncovering the internal signaling pathways that tell cells it's time to die, an event that is often necessary to maintain the well-being of the entire organism. Science. 1996;273:735.
9. Hahm KB, Kim JH, You BM, Kim YS, Cho SW, Yim H, Ahn BO, Kim WB. Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats. Pancreas. 1998;17: 153-157.
10. Kimura K, Shimosegawa T, Abe R, Masamune A, Satoh A, Takasu A, Koizumi M, Toyota T. Low doses of lipopolysaccharide upregulate acinar cell apoptosis in cerulein pancreatitis. Pancreas. 1998;17:120-126.
11. Bhatia M, Wallig MA, Hofbauer B, Lee HS, Frossard JL, Steer ML, Saluja AK. Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem Biophys Res Commun. 1998;246: 476-483.
12. Saluja A, Hofbauer B, Yamaguchi Y, Yamanaka K, Steer M. Induction of apoptosis reduces the severity of caerulein-induced pancreatitis in mice. Biochem Biophys Res Commun. 1996;220:875-878.
13. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol. 1995;269:C1295-C1304.
14. Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege. Immunol Today. 1997;18:240-244.
15. Pinkoski MJ, Droin NM, Lin T, Genestier L, Ferguson TA, Green DR. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion. Proc Nat Acad Sci USA. 2002;99:16174-16179.
16. Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege. Immunol Today, 1997;18:240-244.
17. Barreiro R, Schadlu R, Herndon J, Kaplan HJ, Ferguson TA. The role of Fas-FasL in the development and treatment of ischemic retinopathy. Invest Ophthalmol Visual Sci. 2003;44:1282-1286.
18. Sabelko-Downes KA, Russell JH. The role of fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol. 2000;12:330-335.
19. Sabelko-Downes KA, Russell JH. The role of fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol. 2000;12:330-335.
20. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Nad Acad Sci USA. 1993;90: 1756-1760.
21. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314-317.
22. Murphy ED, Roths JB. Lymphoproliferation. Mouse News Lett. 1978;58:47.
23. Norman J, Yang J, Fink G, Carter G, Ku G, Denham W, Livingston D. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res. 1997;17: 113-118.
24. Beger HG, Gansauge F, Mayer JM. The role of immunocytes in acute and chronic pancreatitis: When friends turn into enemies. Gastroenterology. 2000;118(3): 626-629.
25. Malka D, Vasseur S, Bodeker H, Ortiz EM, Dusetti NJ, Verrando P, Dagorn JC, Iovanna JL. Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology. 2000;119:816-828.
26. Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science. 1998;282:1714-1717.
27. Schulz HU, Niederau C, Klonowski-Stumpe H, Halangk W, Luthen R, Lippert H. Oxidative stress in acute pancreatitis. Hepatogastroenterology. 1999;46:2736-2750.
28. Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest. 1998;101:696-702.
29. Kanno H, Nose M, Itoh J, Taniguchi Y, Kyogoku M. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol. 1992;89:68-73.
30. Demols A, Le Moine O, Desalle F, Quertinmont E, Van Laethem JL, Deviere J. CD4(+) T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology. 2000;118:582-590.
31. Nelson DP, Setser E, Hall DG, Schwartz SM, Hewitt T, Klevitsky R, Osinska H, Bellgrau D, Duke RC, Robbins J. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest. 2000;105:1199-1208.
32. Takeuchi T, Ueki T, Nishimatsu H, Kajiwara T, Ishida T, Jishage K, Ueda O, Suzuki H, Li B, Moriyama N, et al. Accelerated rejection of Fas ligand-expressing heart grafts. J Immunol. 1999;162:518-522.
33. Fecho K, Cohen PL. Fas ligand (gld)- and Fas (Ipr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J Leukocyte Biol. 1998;64:373-383.